News
![Candida_albicans_2](https://pharmaphorum.com/wp-content/uploads/2022/08/Candida_albicans_2.jpg)
FDA advisors back Cidara antifungal rezafungin
An FDA advisory committee has recommended approval of Cidara Therapeutics' once-weekly antifungal therapy rezafungin, setting it up to become the first new option for severe infections caus